MMRV approval should boost immunization rate.(Infectious. Diseases)(measles, mumps, rubella, and varicella): An article from: Family Practice News
This digital document is an article from Family Practice News, published by Thomson Gale on October 1, 2005. The length of the article is 750 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details
Title: MMRV approval should boost immunization rate.(Infectious. Diseases)(measles, mumps, rubella, and varicella)
Author: Diana Mahoney
Publication: Family Practice News (Magazine/Journal)
Date: October 1, 2005
Publisher: Thomson Gale
Volume: 35 Issue: 19 Page: 34(1)
Distributed by Thomson Gale
List Price: $ 5.95
Price: $ 5.95
Get the facts on the chickenpox vaccine, treatment, causes (varicella zoster virus, VZV), symptoms and signs (itchy, red rash).
MMRV approval should boost immunization rate.(Infectious. Diseases)(measles, mumps, rubella, and varicella): An article from: Family Practice News
Related Measles And Chickenpox Products
Orignal From: MMRV approval should boost immunization rate.(Infectious. Diseases)(measles, mumps, rubella, and varicella): An article from: Family Practice News
No comments:
Post a Comment